|
Wednesday, 29 October 2008 |
|
A new study has found that Fosamax and another type of osteoporosis drug can significantly increase a patient’s risk of a serious and potentially fatal irregular heartbeat. The study, which was presented at a meeting of the American College of Chest Physicians, found that patients taking Fosamax or Zometa were 68% more likely to suffer an irregular heartbeat resulting in hospitalization or death. |
|
Read more...
|
|
|
Tuesday, 09 September 2008 |
|
Recent studies have begun to uncover evidence that drugs such as Fosamax, which are designed to strengthen bones, may actually increase the risk of fracture in some patients. Reports have emerged of patients who have suffered a rare type of leg fracture while taking Fosamax or other bisphosphonate drugs, even though they experienced little or no leg trauma. |
|
Read more...
|
|
|
Thursday, 26 June 2008 |
|
A new study has found that long-term use of Fosamax and other “bone-building” drugs can make it harder for a patient’s bones to heal properly. As a result, Fosamax users may be at an increased risk of a certain type of bone fractures. |
|
Read more...
|
|
|
Tuesday, 20 May 2008 |
|
A study of a new experimental osteoporosis drug found that it was significantly more effective at increasing bone density than Fosamax. The new study could eventually spell trouble for Fosamax, whose side effects include a painful condition known as osteonecrosis of the jaw. |
|
Read more...
|
|
|
Monday, 07 January 2008 |
|
The Food and Drug Administration has warned that patients taking Fosamax and other similar bone-building drug may develop severe muscle, joint and bone pain as a result of their treatment. The agency says that it is concerned that doctors may be overlooking these drugs as a possible cause of the disabling pain reported by some patients. |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
| Results 1 - 9 of 19 |